Similar articles

• Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?

  Punt CJ. Punt CJ. Ann Oncol. 2005 Jun;16(6):845-6. doi: 10.1093/annonc/mdi196. Epub 2005 May 12. Ann Oncol. 2005. PMID: 15890668 No abstract available.
• Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.

  Fisher MD. Fisher MD. Clin Colorectal Cancer. 2001 Aug;1(2):85-6. doi: 10.1016/S1533-0028(11)70542-4. Clin Colorectal Cancer. 2001. PMID: 12445365 Review. No abstract available.
• Oxaliplatin combinations as first-line therapy in advanced colorectal cancer.

  [No authors listed] [No authors listed] Clin Colorectal Cancer. 2002 Aug;2(2):78-80. doi: 10.1016/s1533-0028(11)70508-4. Clin Colorectal Cancer. 2002. PMID: 12453320 Clinical Trial. No abstract available.
• Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer.

  Kuebler JP, de Gramont A. Kuebler JP, et al. Semin Oncol. 2003 Aug;30(4 Suppl 15):40-6. doi: 10.1016/s0093-7754(03)00404-4. Semin Oncol. 2003. PMID: 14523794 Review.
• Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.

  Fisher MD. Fisher MD. Clin Colorectal Cancer. 2001 Aug;1(2):82-4. doi: 10.1016/S1533-0028(11)70541-2. Clin Colorectal Cancer. 2001. PMID: 12445364 Review. No abstract available.